Profile
| Metric | Value |
|---|---|
| Full Name | Niagen Bioscience, Inc. |
| Ticker | NASDAQ: CDXC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | chromadex.com |
| Employees | 104 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| PE Ratio | - | |
| Beta | N/A | - |
| Revenue | $100M | |
| Revenue, 1Y Change | +19.18% | |
| EPS | $0.11 | |
| EPS, 1Y Change | +257.14% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:3 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.11 | |
| EPS Estimate | N/A | $0.12 |
| EPS Est. Change | N/A | +6.09% |
| Revenue | $99.60M | |
| Revenue Estimate | N/A | $118.50M |
| Revenue Est. Change | N/A | +18.98% |
| Current Price | - | |
| Price Target | - | $8.10 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.09 | -$0.07 | +22.22% | |
| $0.04 | $0.11 | +205.56% | |
| $0.12 | N/A | +6.09% | |
| $0.20 | N/A | +78.82% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $83.38M | $83.57M | +0.23% | |
| $96.94M | $99.60M | +2.75% | |
| $118.50M | N/A | +18.98% | |
| $143.83M | N/A | +44.41% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| - | ||
| - | ||
| Revenue, 1Y | +19.18% | |
| Revenue, 3Y | +47.66% | |
| EPS, 1Y | +257.14% | |
| EPS, 3Y | +127.50% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | - | |
| SMA 200 | N/A | - |
| SMA 200 vs Price | N/A | - |
| SMA 50 | N/A | - |
| SMA 50 vs Price | N/A | - |
| Beta | N/A | - |
| ATR | N/A | - |
| 14-Day RSI | N/A | - |
| 10-Day Volatility | N/A | - |
| 1-Year Volatility | N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $99.60M | |
| EPS | $0.11 | |
| Gross Profit | $61.59M | |
| Gross Margin | 61.84% | |
| Operating Profit | $7.73M | |
| Operating Margin | 7.76% | |
| Net Income | $8.55M | |
| Net Margin | 8.58% | |
| EBITDA | $9.21M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| 3.57 | ||
| 3.06 | ||
| - | ||
| 7 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $46.09M | |
| $44.51M | ||
| $68.28M | ||
| $64.10M | ||
| $22.18M | ||
| $17.95M | ||
| Total Debt | $2.65M | |
| $994.00K | ||
| $8.53M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $91.87M | ||
| $53.86M | ||
| $38.01M | ||
| $47.84M | ||
| $1.48M | ||
| - | ||
| $305.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $12.11M | ||
| -$143.00K | ||
| $5.37M | ||
| Capex | $163.00K | |
| $11.95M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Ladenburg Thalmann | → | |
| Roth MKM | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Roth MKM | → |
Analyst sentiment
Institutional ownership
Screeners with CDXC
FAQ
What is the ticker symbol for Niagen Bioscience, Inc.?
The ticker symbol for Niagen Bioscience, Inc. is NASDAQ:CDXC
Does Niagen Bioscience, Inc. pay dividends?
No, Niagen Bioscience, Inc. does not pay dividends
What sector is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is in the Healthcare sector
What industry is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is in the Biotechnology industry
What country is Niagen Bioscience, Inc. based in?
Niagen Bioscience, Inc. is headquartered in United States
When did Niagen Bioscience, Inc. go public?
Niagen Bioscience, Inc. initial public offering (IPO) was on June 25, 2008
Is Niagen Bioscience, Inc. in the S&P 500?
No, Niagen Bioscience, Inc. is not included in the S&P 500 index
Is Niagen Bioscience, Inc. in the NASDAQ 100?
No, Niagen Bioscience, Inc. is not included in the NASDAQ 100 index
Is Niagen Bioscience, Inc. in the Dow Jones?
No, Niagen Bioscience, Inc. is not included in the Dow Jones index
When was Niagen Bioscience, Inc. last earnings report?
Niagen Bioscience, Inc.'s most recent earnings report was on May 8, 2025
When does Niagen Bioscience, Inc. report earnings?
The date for Niagen Bioscience, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CDXC Official Website www.chromadex.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1386570/000162828025023127/0001628280-25-023127-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1386570/000162828025009774/0001628280-25-009774-index.htm
- CDXC Profile on Yahoo Finance finance.yahoo.com/quote/CDXC
- CDXC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cdxc